Your browser doesn't support javascript.
loading
Disparities in Integrase Inhibitor Usage in the Modern HIV Treatment Era: A Population-Based Study in a US City.
Spinelli, Matthew A; Hessol, Nancy A; Schwarcz, Sandra K; Scheer, Susan; Gandhi, Monica; Chin Hsu, Ling.
Affiliation
  • Spinelli MA; Division of HIV, ID, and Global Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Hessol NA; Division of HIV, ID, and Global Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Schwarcz SK; San Francisco Department of Public Health, San Francisco, California, USA.
  • Scheer S; Division of HIV, ID, and Global Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Gandhi M; San Francisco Department of Public Health, San Francisco, California, USA.
  • Chin Hsu L; San Francisco Department of Public Health, San Francisco, California, USA.
Open Forum Infect Dis ; 8(7): ofab139, 2021 Jul.
Article in En | MEDLINE | ID: mdl-34250184
ABSTRACT
Integrase inhibitor-based (INSTI) antiretroviral therapy (ART) regimens are preferred for most people with HIV (PWH). We examined factors associated with INSTI use among PWH in San Francisco who started ART in 2009-2016. PWH who experienced homelessness were less likely, and older PWH were more likely, to use an INSTI.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Open Forum Infect Dis Year: 2021 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Open Forum Infect Dis Year: 2021 Document type: Article Affiliation country: United States